Numotion Acquires Retail DME Market Leader SpinLife Creating Broader Portfolio of Independence and Mobility Solutions

Numotion, the nation’s leading and largest provider of products and services that provide mobility, health and personal independence has acquired SpinLife.com the market leader in online retail Durable Medical Equipment (DME) for the aging population as well as people living with disabilities.

SpinLife, established in 1999 and headquartered in Columbus, Ohio, provides a wide variety of DME categories including scooters, lifts, power and manual wheelchairs, and a growing number of exclusive products as well as other accessibility equipment.

“We are extremely excited to announce the acquisition of SpinLife,” said Mike Swinford, Numotion CEO. “SpinLife has an outstanding reputation in the market and is known for their high-touch product expertise and white-glove customer service. Their unique and innovative retail business model and customer focus are incredible complements to our business and brings together the two market leaders in retail and third-party reimbursed products. This powerful combination enables us to expand our capabilities to better serve more customers with a broader portfolio of products and services.”

“With our combined scale and resources, collectively we will do things that have never been done before in this industry,” said Lisa Stein, SpinLife Founder & CEO. “Numotion’s footprint of 150+ brick and mortar locations complement the ecommerce presence, National Service Network and catalog distribution of SpinLife. Together, we will drive speed to market with new products, creative ideas, and innovation that better meet our customers’ changing needs.”

Ms. Stein will be joining the Numotion team as a member of Numotion’s Board of Directors. All SpinLife employees, including their Assistive Technology Professionals (ATPs) and product experts, will also join Numotion, and the SpinLife brand will remain in place. Pattiann McAdams will lead the day-to-day operations and management of Numotion’s new retail division.

“We are thrilled to join the Numotion family,” said Pattiann McAdams, Senior Vice President and General Manager, Retail Division. “The opportunity to serve more customers, all while having a greater impact on improving accessibility and inclusion across the communities we serve, is extremely exciting and we look forward to partnering with the Numotion teams to make this happen.”

Fried, Frank, Harris, Shriver & Jacobson LLP and Foley & Lardner LLP acted as legal counsel to Numotion for this transaction. Numotion engaged global professional services firm KPMG to provide due diligence services.

SourceNumotion

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”